Home > Healthcare > Medical Devices > Diagnostic Devices > Platelet Aggregation Devices Market

Platelet Aggregation Devices Market Size

Report ID: GMI8290
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Platelet Aggregation Devices Market Size

Platelet Aggregation Devices Market size was valued at around USD 653.3 million in 2023 and is estimated to grow at over 8.9% CAGR from 2024 to 2032. The rising incidence of chronic diseases and cardiovascular disorders is expected to drive significant growth in the market.

To get key market trends

Download Free Sample

The increasing prevalence of chronic diseases is attributed to be the primary driving factor behind the market expansion. Factors such as poor health behaviors, genetic predisposition, aging population, and obesity contributes to this trend. For example, chronic conditions like heart diseases and cancers are leading causes of mortality and morbidity in the U.S., as reported by the Centers for Disease Control and Prevention (CDC).

Platelet Aggregation Devices Market Report Attributes
Report Attribute	Details
Base Year:	2023
Platelet Aggregation Devices Market Size in 2023:	USD 653.3 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	8.9%
2032 Value Projection:	USD 1.4 Billion
Historical Data for:	2018 - 2023
No. of Pages:	120
Tables, Charts & Figures:	242
Segments covered:	Product Type, Application, End-use, and Region
Growth Drivers:	Rising incidence of chronic diseases Technological advancements in platelet aggregometers Growing patient population related to cardiovascular diseases
Pitfalls & Challenges:	High cost of devices and shortage of skilled personnel

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, in New York State, over 40% of adults suffer from chronic diseases, which account for 23% of all hospitalizations. Consequently, the rising burden of chronic diseases is anticipated to significantly boost the demand for diagnostic tools such as platelet aggregation devices.

Platelet aggregation devices are medical instruments or systems used to assess the ability of blood platelets (a type of blood cell involved in clotting) to clump together and form clots. These devices are primarily utilized in clinical settings to diagnose and monitor various conditions related to blood clotting disorders, cardiovascular diseases, and the effectiveness of antiplatelet medications.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Platelet aggregation devices market size was USD 653.3 million in 2023 and is expected to register 8.9% CAGR from 2024-2032 owing to the rising incidence of chronic diseases and cardiovascular disorders worldwide.

Platelet aggregation devices industry from the hospitals segment reached USD 303.6 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their comprehensive healthcare services, including emergency care, surgery, and specialized treatments.

North America platelet aggregation devices industry recorded USD 229.4 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to rising strategic collaborations and partnerships with healthcare institutions, research organizations, and academic centers in the region.

Chrono-Log Corporation, Drucker Diagnostics, F. Hoffmann-La Roche Ltd., Haemonetics Corporation, Helena Laboratories Corporation, Siemens Healthineers AG, Sienco, Inc., Sysmex Corporation, and Werfen, are some of the major platelet aggregation devices companies worldwide.